Terms: = Breast cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1
761 results:
1. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
[TBL] [Abstract] [Full Text] [Related]
2. Parabens promotes invasive properties of multiple human cells: A potential cancer-associated adverse outcome pathway.
Wang L; Chen L; Schlenk D; Li F; Liu J
Sci Total Environ; 2024 May; 926():172015. PubMed ID: 38547973
[TBL] [Abstract] [Full Text] [Related]
3. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
PeerJ; 2024; 12():e16958. PubMed ID: 38410801
[TBL] [Abstract] [Full Text] [Related]
4. Dual effect of vitamin D
Łabędź N; Anisiewicz A; Stachowicz-Suhs M; Banach J; Kłopotowska D; Maciejczyk A; Gazińska P; Piotrowska A; Dzięgiel P; Matkowski R; Wietrzyk J
BMC Cancer; 2024 Feb; 24(1):209. PubMed ID: 38360633
[TBL] [Abstract] [Full Text] [Related]
5. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
[TBL] [Abstract] [Full Text] [Related]
6. Application of the Key Characteristics Framework to Identify Potential breast Carcinogens Using Publicly Available
Kay JE; Brody JG; Schwarzman M; Rudel RA
Environ Health Perspect; 2024 Jan; 132(1):17002. PubMed ID: 38197648
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of gastrointestinal symptoms trajectories using omega-3 and inflammatory biomarkers in early-stage breast cancer patients receiving chemotherapy.
Arcos D; Ng DQ; Ke Y; Toh YL; Chan A
Support Care Cancer; 2024 Jan; 32(1):76. PubMed ID: 38170327
[TBL] [Abstract] [Full Text] [Related]
8. n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells.
Gurav P; Patade T; Hajare S; Kedar RN
Med Oncol; 2023 Nov; 41(1):2. PubMed ID: 38017288
[TBL] [Abstract] [Full Text] [Related]
9. Tetracaine downregulates matrix metalloproteinase activity and inhibits invasiveness of strongly metastatic MDA-MB-231 human breast cancer cells.
Keleş D; Sipahi M; İnanç-Sürer Ş; Djamgoz MB; Oktay G
Chem Biol Interact; 2023 Nov; 385():110730. PubMed ID: 37806380
[TBL] [Abstract] [Full Text] [Related]
10. CLDN6 Suppresses Migration and Invasion of MCF-7 and SKBR-3 breast cancer Cells by Blocking the SMAD/Snail/MMP-2/9 Axis.
Liu T; Jiang L; Bai Q; Wu S; Yu X; Wu T; Wang J; Zhang X; Li H; Zhao K; Wang L
Bull Exp Biol Med; 2023 Jul; 175(3):376-381. PubMed ID: 37566248
[TBL] [Abstract] [Full Text] [Related]
11. Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease.
Molière S; Jaulin A; Tomasetto CL; Dali-Youcef N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445827
[TBL] [Abstract] [Full Text] [Related]
12. Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative breast cancer Cells.
Agnello L; d'Argenio A; Caliendo A; Nilo R; Zannetti A; Fedele M; Camorani S; Cerchia L
Cells; 2023 Jul; 12(13):. PubMed ID: 37443843
[TBL] [Abstract] [Full Text] [Related]
13. Factors affecting women's participation in mammography screening in Nordic countries: A systematic review.
Sterlingova T; Nylander E; Almqvist L; Møller Christensen B
Radiography (Lond); 2023 Aug; 29(5):878-885. PubMed ID: 37421878
[TBL] [Abstract] [Full Text] [Related]
14. Erythrocyte membrane
Zhang ZL; Ho SC; Shi DD; Zhan XX; Wu QX; Xu L; Zhang CX
Br J Nutr; 2024 Jan; 131(1):103-112. PubMed ID: 37381894
[TBL] [Abstract] [Full Text] [Related]
15. The cytotoxic effects of indoleamine 2, 3-dioxygenase inhibitors on triple negative breast cancer cells upon tumor necrosis factor α stimulation.
Bilir C; Eskiler GG; Bilir F
J Cancer Res Ther; 2023 Apr; 19(Supplement):S74-S80. PubMed ID: 37147986
[TBL] [Abstract] [Full Text] [Related]
16. The Potential of DHA as cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials.
de Freitas Rodrigues J; Philippsen HK; Dolabela MF; Nagamachi CY; Pieczarka JC
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111226
[TBL] [Abstract] [Full Text] [Related]
17. Physiologically-based pharmacokinetic/pharmacodynamic modeling to predict tumor growth inhibition and the efficacious dose of selective estrogen receptor degraders in humans.
Ganti A; Yu S; Sharpnack D; Ingalla E; De Bruyn T
Biopharm Drug Dispos; 2023 Aug; 44(4):301-314. PubMed ID: 37102506
[TBL] [Abstract] [Full Text] [Related]
18. The invariant chain CD74 protein is a cell surface binding partner of timp-1 in breast cancer cells.
Høeberg M; Noer JB; Vistesen MV; Bartels A; Bech EM; Nygård SB; Lademann U; Stenvang J; Liu S; Fuglsang AT; Brünner N; Moreira JMA
Mol Oncol; 2023 Aug; 17(8):1595-1612. PubMed ID: 37081824
[TBL] [Abstract] [Full Text] [Related]
19. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and Safety of Minimally Invasive Thyroid Surgery: A Network Meta-Analysis.
Kim DH; Kim SW; Kim GJ; Basurrah MA; Hwang SH
Laryngoscope; 2023 Oct; 133(10):2470-2479. PubMed ID: 36892037
[TBL] [Abstract] [Full Text] [Related]
[Next]
